Dr Carole Sue Zawid, APRN, PHD in Adventura, FL - Medicare

Dr Carole Sue Zawid, APRN, PHD is a medicare enrolled "Clinical Nurse Specialist - Psychiatric/mental Health" in Adventura, Florida. Her current practice location is 6000 Island Blvd, Apt 1005, Adventura, Florida. You can reach out to her office (for appointments etc.) via phone at (609) 226-7601.

Dr Carole Sue Zawid is licensed to practice in New Jersey (license number 26NC03404800) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1740356484.

Contact Information

	Dr Carole Sue Zawid, APRN, PHD
	6000 Island Blvd, Apt 1005, Adventura, FL 33160-3761
	(609) 226-7601
	(305) 749-3255

Provider's Profile

Full Name	Dr Carole Sue Zawid
Gender	Female
Speciality
Experience	Years
Location	6000 Island Blvd, Adventura, Florida
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Carole Sue Zawid attended and graduated from in

NPI Data:

NPI Number: 1740356484
Provider Enumeration Date: 11/27/2006
Last Update Date: 06/12/2023

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Dr Carole Sue Zawid such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1740356484	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
163WP0808X	Registered Nurse - Psychiatric/mental Health	26NC03404800 (New Jersey)	Secondary
364SP0808X	Clinical Nurse Specialist - Psychiatric/mental Health	11004793 (Florida)	Secondary
364SP0808X	Clinical Nurse Specialist - Psychiatric/mental Health	9175150 (Florida)	Secondary
364SP0808X	Clinical Nurse Specialist - Psychiatric/mental Health	26NC03404800 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Carole Sue Zawid is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Carole Sue Zawid, APRN, PHD 6000 Island Blvd, Apt 1005, Adventura, FL 33160-3761 Ph: (609) 226-7601	Dr Carole Sue Zawid, APRN, PHD 6000 Island Blvd, Apt 1005, Adventura, FL 33160-3761 Ph: (609) 226-7601

News Archive

Nature News examines how scientists, farmers are working to meet the growing demand for artemisinin

"From bust to boom to bust again: artemisinin, the key ingredient of front-line antimalarial drugs, is entering the third chapter of its turbulent history," Nature News writes in an article that examines the challenges scientists and farmers are facing as they attempt to keep up with the growing demand for the compound just as a "$343-million initiative starts to battle malaria through hugely subsidized medicines."

Significant step forward in the search for a vaccine against Group B meningococcal disease

For a long time, doctors and scientists have suspected that Neisseria lactamica, a harmless germ carried mostly by children under the age of five years, is the key to the development of natural immunity to meningococcal meningitis and septicaemia (blood poisoning).

Agilent Technologies introduces SureSelect Human All Exon v2 Target Enrichment kit for cancer assay

Agilent Technologies Inc.today introduced the SureSelect Human All Exon v2 Target Enrichment kit, which was developed in close collaboration with the Broad Institute of MIT and Harvard. The kit, the 15th SureSelect product in Agilent's portfolio, is a single tube assay that allows researchers to streamline experiments by sequencing the expressed genome while discarding regions not of interest.

Baked goods made from hydrolyzed wheat flour are not toxic to celiac disease patients

Baked goods made from hydrolyzed wheat flour are not toxic to celiac disease patients, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association Institute.

Outbreak of hand, foot and mouth disease kills 81 children in Vietnam

"Vietnam's prime minister has put the country on alert as an outbreak of hand, foot and mouth disease continues to surge, killing 81 children and sickening more than 32,000 people nationwide so far this year, officials said Friday," the Associated Press reports.

Dr Carole Sue Zawid, APRN, PHD - Medicare in Adventura, FL